National Institute of Occupational Safety and Health (2012). «Respiratory Diseases Input: Occupational Risks». NIOSH Program Portfolio. Centers for Disease Control and Prevention. Ανακτήθηκε στις 30 Δεκεμβρίου 2012.
Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, Aboyans V (December 2012). «Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010». Lancet380 (9859): 2163–96. doi:10.1016/S0140-6736(12)61729-2. PMID23245607.
GBD 2013 Mortality and Causes of Death, Collaborators (17 December 2014). «Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.». Lancet. doi:10.1016/S0140-6736(14)61682-2. PMID25530442.
Craven, V; Everard, ML (January 2013). «Protracted bacterial bronchitis: reinventing an old disease». Archives of Disease in Childhood98 (1): 72–76. doi:10.1136/archdischild-2012-302760. PMID23175647.
Mohamed Hoesein, FA; Zanen, P; Lammers, JW (June 2011). «Lower limit of normal or FEV1/FVC<0.70 in diagnosing COPD: an evidence-based review». Respiratory medicine105 (6): 907–915. doi:10.1016/j.rmed.2011.01.008. PMID21295958.
Wanger, J; Clausen, JL; Coates, A; Pedersen, OF; Brusasco, V; Burgos, F; Casaburi, R; Crapo, R και άλλοι. (September 2005). «Standardisation of the measurement of lung volumes». The European respiratory journal: official journal of the European Society for Clinical Respiratory Physiology26 (3): 511–522. doi:10.1183/09031936.05.00035005. PMID16135736.
Spencer, S; Karner, C; Cates, CJ; Evans, DJ (2011). «Inhaled corticosteroids versus long acting beta(2)-agonists for chronic obstructive pulmonary disease». Cochrane Database of Systematic Reviews12 (CD007033): CD007033. doi:10.1002/14651858.CD007033.pub3. PMID22161409.
Karner, C; Chong, J; Poole, P (2012). «Tiotropium versus placebo for chronic obstructive pulmonary disease». Cochrane Database of Systematic Reviews7 (CD009285): CD009285. doi:10.1002/14651858.CD009285.pub2. PMID22786525.
Poole, P; Black, PN; Cates, CJ (2012). «Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease». Cochrane Database of Systematic Reviews8 (CD001287): CD001287. doi:10.1002/14651858.CD001287.pub4. PMID22895919.
Algusti AG, και άλλοι. (2017). «Definition and Overview». Global Strategy for the Diagnosis, Management and Prevention of COPD. Global Initiative for Chronic Obstructive Lung Disease (GOLD). σελίδες 6–17.
Vestbo, Jørgen (2013). «Diagnosis and Assessment»(PDF). Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. Global Initiative for Chronic Obstructive Lung Disease. σελίδες 9–17. Αρχειοθετήθηκε από το πρωτότυπο(PDF) στις 4 Οκτωβρίου 2013. Ανακτήθηκε στις 27 Νοεμβρίου 2015.
Braman, SS (January 2006). «Chronic cough due to acute bronchitis: ACCP evidence-based clinical practice guidelines.». Chest129 (1 Suppl): 95S-103S. PMID16428698.
Fleming, DM; Elliot, AJ (March 2007). «The management of acute bronchitis in children.». Expert opinion on pharmacotherapy8 (4): 415-26. PMID17309336.
Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, Aboyans V (December 2012). «Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010». Lancet380 (9859): 2163–96. doi:10.1016/S0140-6736(12)61729-2. PMID23245607.
GBD 2013 Mortality and Causes of Death, Collaborators (17 December 2014). «Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.». Lancet. doi:10.1016/S0140-6736(14)61682-2. PMID25530442.
Smith, SM; Schroeder, K; Fahey, T (24 November 2014). «Over-the-counter (OTC) medications for acute cough in children and adults in community settings.». The Cochrane database of systematic reviews11: CD001831. PMID25420096.
Becker, LA; Hom, J; Villasis-Keever, M; van der Wouden, JC (6 July 2011). «Beta2-agonists for acute bronchitis.». The Cochrane database of systematic reviews (7): CD001726. PMID21735384.
Smith, SM; Fahey, T; Smucny, J; Becker, LA (1 March 2014). «Antibiotics for acute bronchitis.». The Cochrane database of systematic reviews3: CD000245. PMID24585130.
Craven, V; Everard, ML (January 2013). «Protracted bacterial bronchitis: reinventing an old disease». Archives of Disease in Childhood98 (1): 72–76. doi:10.1136/archdischild-2012-302760. PMID23175647.
Willemse, BW; Postma, DS; Timens, W; ten Hacken, NH (March 2004). «The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation». The European respiratory journal: official journal of the European Society for Clinical Respiratory Physiology23 (3): 464–476. PMID15065840.
Mohamed Hoesein, FA; Zanen, P; Lammers, JW (June 2011). «Lower limit of normal or FEV1/FVC<0.70 in diagnosing COPD: an evidence-based review». Respiratory medicine105 (6): 907–915. doi:10.1016/j.rmed.2011.01.008. PMID21295958.
Wanger, J; Clausen, JL; Coates, A; Pedersen, OF; Brusasco, V; Burgos, F; Casaburi, R; Crapo, R και άλλοι. (September 2005). «Standardisation of the measurement of lung volumes». The European respiratory journal: official journal of the European Society for Clinical Respiratory Physiology26 (3): 511–522. doi:10.1183/09031936.05.00035005. PMID16135736.
Spencer, S; Karner, C; Cates, CJ; Evans, DJ (2011). «Inhaled corticosteroids versus long acting beta(2)-agonists for chronic obstructive pulmonary disease». Cochrane Database of Systematic Reviews12 (CD007033): CD007033. doi:10.1002/14651858.CD007033.pub3. PMID22161409.
Karner, C; Chong, J; Poole, P (2012). «Tiotropium versus placebo for chronic obstructive pulmonary disease». Cochrane Database of Systematic Reviews7 (CD009285): CD009285. doi:10.1002/14651858.CD009285.pub2. PMID22786525.
Poole, P; Black, PN; Cates, CJ (2012). «Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease». Cochrane Database of Systematic Reviews8 (CD001287): CD001287. doi:10.1002/14651858.CD001287.pub4. PMID22895919.
National Heart Lung and Blood Institute (2009). «Who Is at Risk for Bronchitis?». National Institutes of Health. Αρχειοθετήθηκε από το πρωτότυπο στις 4 Ιανουαρίου 2013. Ανακτήθηκε στις 30 Δεκεμβρίου 2012.
Vestbo, Jørgen (2013). «Diagnosis and Assessment»(PDF). Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. Global Initiative for Chronic Obstructive Lung Disease. σελίδες 9–17. Αρχειοθετήθηκε από το πρωτότυπο(PDF) στις 4 Οκτωβρίου 2013. Ανακτήθηκε στις 27 Νοεμβρίου 2015.
National Heart Lung and Blood Institute (2009). «Who Is at Risk for Bronchitis?». National Institutes of Health. Αρχειοθετήθηκε από το πρωτότυπο στις 4 Ιανουαρίου 2013. Ανακτήθηκε στις 30 Δεκεμβρίου 2012.
